In this episode, Hope Rugo, MD, of City of Hope, shares insights from the SERENA-6 trial, which evaluated ctDNA-guided treatment changes for patients with HR-positive/HER2-negative metastatic breast cancer.
Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at editorial@physweekly.com!
